TGF-B1 as a Prognostic Indicator in Advanced Gastric Cancer
Author Information
Author(s): M Nakamura, M Katano, A Kuwahara, K Fujimoto, K Miyazaki, T Morisaki, M Mori
Primary Institution: Saga Medical School
Hypothesis
TGF-B1 expression at the site of carcinoma may contribute to highly malignant behavior in advanced gastric tumors.
Conclusion
TGF-B1 mRNA expression in gastric biopsy specimens is a significant preoperative prognostic indicator for advanced gastric carcinoma.
Supporting Evidence
- TGF-B1-positive patients had a shorter overall survival compared to TGF-B1-negative patients.
- Significant correlations were found between TGF-B1 mRNA expression and tumor stage.
- TGF-B1 mRNA expression was identified as an independent prognostic factor.
Takeaway
This study found that a specific protein, TGF-B1, in stomach cancer samples can help doctors predict how aggressive the cancer is.
Methodology
The study used reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze TGF-B1 mRNA in biopsy specimens from patients with advanced gastric carcinoma.
Limitations
The study excluded early-stage patients and focused only on advanced cases.
Participant Demographics
The study involved 42 patients with advanced gastric carcinoma, with a follow-up duration ranging from 4 to 37 months.
Statistical Information
P-Value
0.0014
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website